These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 17328890

  • 1. A novel member of the calcitonin gene-related peptide family, calcitonin receptor-stimulating peptide, inhibits the formation and activity of osteoclasts.
    Notoya M, Arai R, Katafuchi T, Minamino N, Hagiwara H.
    Eur J Pharmacol; 2007 Apr 10; 560(2-3):234-9. PubMed ID: 17328890
    [Abstract] [Full Text] [Related]

  • 2. Comparisons between the effects of calcitonin receptor-stimulating peptide and intermedin and other peptides in the calcitonin family on bone resorption and osteoclastogenesis.
    Granholm S, Henning P, Lerner UH.
    J Cell Biochem; 2011 Nov 10; 112(11):3300-12. PubMed ID: 21748786
    [Abstract] [Full Text] [Related]

  • 3. Expression of the calcitonin receptor, calcitonin receptor-like receptor, and receptor activity modifying proteins during osteoclast differentiation.
    Granholm S, Lundberg P, Lerner UH.
    J Cell Biochem; 2008 Jun 01; 104(3):920-33. PubMed ID: 18384073
    [Abstract] [Full Text] [Related]

  • 4. Structure and biological properties of three calcitonin receptor-stimulating peptides, novel members of the calcitonin gene-related peptide family.
    Katafuchi T, Minamino N.
    Peptides; 2004 Nov 01; 25(11):2039-45. PubMed ID: 15501538
    [Abstract] [Full Text] [Related]

  • 5. Effects of calcitonin on the function of human osteoclast-like cells formed from CD14-positive monocytes.
    Yamamoto Y, Yamamoto Y, Udagawa N, Okumura S, Mizoguchi T, Take I, Yamauchi H, Yamauchi H, Noguchi T, Takahashi N.
    Cell Mol Biol (Noisy-le-grand); 2006 May 15; 52(3):25-31. PubMed ID: 17535751
    [Abstract] [Full Text] [Related]

  • 6. Genomic and expression analysis of canine calcitonin receptor-stimulating peptides and calcitonin/calcitonin gene-related peptide.
    Osaki T, Katafuchi T, Minamino N.
    J Biochem; 2008 Oct 15; 144(4):419-30. PubMed ID: 18558619
    [Abstract] [Full Text] [Related]

  • 7. Identification and biological activity of ovine and caprine calcitonin receptor-stimulating peptides 1 and 2.
    Charles CJ, Katafuchi T, Yandle TG, Minamino N.
    J Endocrinol; 2008 Aug 15; 198(2):429-37. PubMed ID: 18483201
    [Abstract] [Full Text] [Related]

  • 8. Berberine inhibits RANKL-induced osteoclast formation and survival through suppressing the NF-kappaB and Akt pathways.
    Hu JP, Nishishita K, Sakai E, Yoshida H, Kato Y, Tsukuba T, Okamoto K.
    Eur J Pharmacol; 2008 Feb 02; 580(1-2):70-9. PubMed ID: 18083161
    [Abstract] [Full Text] [Related]

  • 9. The role of peptides and receptors of the calcitonin family in the regulation of bone metabolism.
    Naot D, Cornish J.
    Bone; 2008 Nov 02; 43(5):813-8. PubMed ID: 18687416
    [Abstract] [Full Text] [Related]

  • 10. Paeonol inhibits RANKL-induced osteoclastogenesis by inhibiting ERK, p38 and NF-kappaB pathway.
    Tsai HY, Lin HY, Fong YC, Wu JB, Chen YF, Tsuzuki M, Tang CH.
    Eur J Pharmacol; 2008 Jun 24; 588(1):124-33. PubMed ID: 18495114
    [Abstract] [Full Text] [Related]

  • 11. Isolation and characterization of a glycine-extended form of calcitonin receptor-stimulating peptide-1: another biologically active form of calcitonin receptor-stimulating peptide-1.
    Katafuchi T, Hamano K, Kikumoto K, Minamino N.
    Peptides; 2005 Dec 24; 26(12):2616-23. PubMed ID: 16023259
    [Abstract] [Full Text] [Related]

  • 12. Amelogenin is a negative regulator of osteoclastogenesis via downregulation of RANKL, M-CSF and fibronectin expression in osteoblasts.
    Nishiguchi M, Yuasa K, Saito K, Fukumoto E, Yamada A, Hasegawa T, Yoshizaki K, Kamasaki Y, Nonaka K, Fujiwara T, Fukumoto S.
    Arch Oral Biol; 2007 Mar 24; 52(3):237-43. PubMed ID: 17101114
    [Abstract] [Full Text] [Related]

  • 13. Calcitonin receptor regulation and responsiveness to calcitonin in human osteoclast-like cells prepared in vitro using receptor activator of nuclear factor-kappaB ligand and macrophage colony-stimulating factor.
    Samura A, Wada S, Suda S, Iitaka M, Katayama S.
    Endocrinology; 2000 Oct 24; 141(10):3774-82. PubMed ID: 11014233
    [Abstract] [Full Text] [Related]

  • 14. Inhibitory effect of (-)-saucerneol on osteoclast differentiation and bone pit formation.
    Kim SN, Kim MH, Kim YS, Ryu SY, Min YK, Kim SH.
    Phytother Res; 2009 Feb 24; 23(2):185-91. PubMed ID: 18690659
    [Abstract] [Full Text] [Related]

  • 15. Calcitonin receptor-stimulating peptide: Its evolutionary and functional relationship with calcitonin/calcitonin gene-related peptide based on gene structure.
    Katafuchi T, Yasue H, Osaki T, Minamino N.
    Peptides; 2009 Sep 24; 30(9):1753-62. PubMed ID: 19540291
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of osteoclast differentiation and bone resorption by sauchinone.
    Han KY, Yang D, Chang EJ, Lee Y, Huang H, Sung SH, Lee ZH, Kim YC, Kim HH.
    Biochem Pharmacol; 2007 Sep 15; 74(6):911-23. PubMed ID: 17662251
    [Abstract] [Full Text] [Related]

  • 17. Calcitonin receptor-stimulating peptide, a new member of the calcitonin gene-related peptide family. Its isolation from porcine brain, structure, tissue distribution, and biological activity.
    Katafuchi T, Kikumoto K, Hamano K, Kangawa K, Matsuo H, Minamino N.
    J Biol Chem; 2003 Apr 04; 278(14):12046-54. PubMed ID: 12556539
    [Abstract] [Full Text] [Related]

  • 18. [Effects of calcitonin on osteoclast].
    Yamamoto Y, Noguchi T, Takahashi N.
    Clin Calcium; 2005 Mar 04; 15(3):147-51. PubMed ID: 15741694
    [Abstract] [Full Text] [Related]

  • 19. Bacterial lipopolysaccharide induces osteoclast formation in RAW 264.7 macrophage cells.
    Islam S, Hassan F, Tumurkhuu G, Dagvadorj J, Koide N, Naiki Y, Mori I, Yoshida T, Yokochi T.
    Biochem Biophys Res Commun; 2007 Aug 24; 360(2):346-51. PubMed ID: 17597583
    [Abstract] [Full Text] [Related]

  • 20. NF-kappaB inhibitor dehydroxymethylepoxyquinomicin suppresses osteoclastogenesis and expression of NFATc1 in mouse arthritis without affecting expression of RANKL, osteoprotegerin or macrophage colony-stimulating factor.
    Kubota T, Hoshino M, Aoki K, Ohya K, Komano Y, Nanki T, Miyasaka N, Umezawa K.
    Arthritis Res Ther; 2007 Aug 24; 9(5):R97. PubMed ID: 17892600
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.